Background: Hispanics are a highly admixed population. Pooled Cohort Equation (PCE) excluded them in its derivation. We analyzed Hispanic background and genetic ancestry in relation to atherosclerotic cardiovascular disease (ASCVD) risk. Methods: We included 966 Hispanics from Multi-Ethnic Study of Atherosclerosis (MESA), aged 44-75 years and free of diabetes/prior CVD. Statin users and those with LDL-C>190 mg/dL were excluded. Continental genetic ancestry (West African [AA], European [EA]) was estimated by ADMIXTURE software. Predicted ASCVD events (myocardial infarction, stroke, coronary heart disease death) based on non-Hispanic White (NHW) and non-Hispanic Black (NHB) PCE versions, were compared with observed events based on 10-years Kaplan-Meier Estimates and presented as predicted-to-observed (P/O) ratios across Hispanic backgrounds and >median genetic ancestry. Risk discrimination was assessed by Harrell’s C-statistic based on Cox models. Results: MESA Hispanics included 504 Mexicans [ME], 284 Caribbean [CA] and 178 Other Hispanics [OH]. At 10-years, there were 179 ASCVD events: 107 ME; 49 CA; 23 OH. PCE overestimates ASCVD risk (reflected by P/O ratio >1.0). Using the NHW PCE, all Hispanics had a similar P/O ratio compared to NHW in the low-risk category, and lower P/O ratio compared to NHW in the high-risk category. The extent of overestimation varied across disaggregated Hispanic background (least in ME intermediate risk; most in CA high risk category). Higher P/O ratios were observed among Hispanics of >median AA ancestry and lowest in Hispanics of >median EA ancestry (Figure 1). Harrell’s C-statistic showed no statistically significant difference within groups. Conclusion: Disaggregating Hispanics by background and ancestry led to variability in PCE performance with greater overestimation of ASCVD risk for those of CA background or with >median AA compared to those of ME background or >median EA. The relationship between ethnicity, ancestry, and ASCVD risk in Hispanics should be further explored.
No takes yet. Share an insight, caveat, or question.
Nriagu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: